Innovations, Utilization, and Safety of Psychiatric Drugs: Current Trends and Future Directions
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: 30 March 2026 | Viewed by 1238
Special Issue Editor
Interests: psychiatric medicine; community pharmacies; pharmacology; a dverse drug reaction
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Basic biology and pharmacology research in the field of psychiatric diseases has witnessed significant advancements in recent decades, yet challenges remain in clinical practice, especially concerning the efficacy and safety of marketed psychiatric medicine. The aim of this Special Issue, therefore, is to provide a comprehensive platform for exploring the latest developments in psychiatric pharmacotherapy, addressing the critical need for safe and effective treatment options for a variety of psychiatric patients, ranging from the spectrum of depressive disorders to psychotic disorders. By gathering insights from these critical areas, the aim of this Special Issue is to foster a deeper understanding of the current status and future directions of psychiatric drug research and practice. Thus, we welcome submissions from researchers, clinicians, and scholars who are working to advance the field and improve patient care in all fields related to psychiatric disorders.
Dr. Josipa Bukić
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- psychiatric diseases
- psychiatric medicine
- psychiatric pharmacotherapy
- psychiatric drugs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
